Anti-oxidative stress preparation as well as preparation method and application thereof
The antioxidant stress preparations combined with schisandraein and spirulina and chitosan are embedded by embedding antioxidant stress by engaging in milk exosomes, using two-way communication mediated by intestinal probiotics to coordinate antioxidant stress, and the existing antioxidant components are solved. The poor problem has achieved efficient prevention and treatment of oxidative stress-related diseases.
Patent Information
- Application Number
- CN202411004898.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-25
AI Technical Summary
The existing antioxidant components are poor in preventing and treating oxidative stress-related diseases due to poor water solubility, poor targeting, low bioavailability, and lack of bidirectional intestinal tract, brain, liver and other major organs mediated by intestinal probiotics. Functional food for communication.
Using a three-dimensional framework formed by the interaction between active exosomes made of Schisandra ethinocerosine embedding of Schisandra ethinin and spirulina and chitosan, combined with lactic acid bacteria, an antioxidant stress preparation was prepared, which was mediated by intestinal probiotics. two-way communication, coordinated antioxidant stress.
It significantly extends the lifespan of C. elegans, reduces lipofuscin and ROS levels, improves antioxidant enzyme activity, significantly delays aging, and has the effect of preventing and treating Alzheimer's disease and liver diseases.
Smart Images

Figure CN118947903A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of food, and relates to an antioxidant stress preparation and a preparation method and application thereof. Background Art
[0002] Excessive free radicals or excessive consumption of oxidative substances can lead to oxidative stress, which can cause aging, neurodegenerative diseases, liver dysfunction, cardiovascular disease, inflammatory response, tumors, etc. At present, most people use a single antioxidant ingredient to prevent and treat oxidative stress-related diseases, but the anti-oxidative stress effect is unsatisfactory due to the poor water solubility, poor targeting, and low bioavailability of most antioxidant ingredients. In recent years, starting from the two-way communication between the intestine and major organs such as the brain, liver, and heart mediated by intestinal probiotics, combined with the strategy of anti-oxidative stress, it has provided a new idea for the efficient prevention and treatment of oxidative stress-related diseases, but so far no such functional food has been developed. Summary of the invention
[0003] The main purpose of the present invention is to delay aging and prevent and treat oxidative stress-related diseases, including neurodegenerative diseases, liver diseases such as hyperglycemia and hyperlipidemia, through two-way communication between the intestine and major organs such as the brain, liver, and heart mediated by intestinal probiotics, from the dimension of synergistic anti-oxidative stress. Based on this, the present invention proposes an anti-oxidative stress preparation and its preparation method and application.
[0004] In a first aspect, the present invention provides an antioxidant stress preparation, wherein the antioxidant stress food is composed of internal nanospheres and an external three-dimensional framework;
[0005] The nanospheres are made of milk exosomes encapsulating schisandra chinensis B to form active exosomes;
[0006] The three-dimensional framework is formed by the interaction and connection of lactic acid bacteria, spirulina and chitosan.
[0007] Furthermore, in the anti-oxidative stress preparation provided by the present invention, the particle size of active exosomes is 1449.64±102.35nm;
[0008] The three-dimensional framework is a three-dimensional structure with a pore size of 10 to 60 μm.
[0009] In a second aspect, the present invention provides a method for preparing an antioxidant stress preparation, comprising the following steps:
[0010] (1) Preparation of bovine milk exosomes: fresh bovine milk is centrifuged at low temperature to obtain skim milk; after adjusting the pH of the skim milk, it is centrifuged at low temperature to obtain a whey solution; the whey solution is filtered and centrifuged at low temperature to obtain a yellow colloidal precipitate; the yellow colloidal precipitate is washed with a PBS solution and dispersed in a PBS solution, and the obtained bovine milk exosomes are stored for later use;
[0011] (2) Preparation of active exosomes: The milk exosomes were diluted and mixed with an ethanol solution containing schisandrin B to remove unencapsulated schisandrin B and obtain active exosomes;
[0012] (3) After the active exosomes, spirulina, and chitosan are completely mixed, lactic acid bacteria are added, mixed and reacted, and an antioxidant stress-resistant food is prepared.
[0013] Specifically, in step (1), the pH of skim milk is adjusted to 4.6 with 2M hydrochloric acid, and the storage temperature of milk exosomes is -20°C.
[0014] Specifically, the dilution of the milk exosomes in step (2) is as follows: 2 mL of the milk exosomes in step (1) is diluted to 10 mL; the volume of the ethanol solution containing schisandrin B is 10 mL, and the concentration of the ethanol solution containing schisandrin B is 5 mg·mL -1 ; The mixing reaction time is 24h.
[0015] Specifically, the volume of active exosomes in step (3) was 20 mL, and the concentration of active exosomes was 5 μg mL -1 ; The mass of Spirulina is 45-90 mg; The mass of chitosan is 100 mg; The mass of lactic acid bacteria is 10-55 mg.
[0016] Preferably, the volume of active exosomes is 20 mL and the concentration of active exosomes is 5 μg mL -1 ; The mass of Spirulina is 90 mg; The mass of chitosan is 100 mg; The mass of lactic acid bacteria is 10 mg.
[0017] Furthermore, in the preparation method of the antioxidant stress preparation provided by the present invention, the final concentration of lactic acid bacteria is 1×10 10 CFU·mL -1 .
[0018] In a third aspect, the antioxidant stress preparation or the preparation method of the present invention is used in preparing food having the following effects, wherein the effects include: preventing or treating diseases caused by oxidative stress;
[0019] The disease comprises at least one of a neurodegenerative disease and a liver disease;
[0020] The neurodegenerative disease is Alzheimer's disease.
[0021] In a fourth aspect, the antioxidant stress preparation of the present invention or the preparation method thereof is used in the preparation of a food additive having the following effects, wherein the effects include: preventing or treating diseases caused by oxidative stress;
[0022] The disease comprises at least one of a neurodegenerative disease and a liver disease;
[0023] The neurodegenerative disease is Alzheimer's disease.
[0024] In a fifth aspect, the anti-oxidative stress preparation of the present invention or the preparation method thereof is used in the preparation of a drug having the following effects, wherein the effects include: preventing or treating diseases caused by oxidative stress;
[0025] The disease comprises at least one of a neurodegenerative disease and a liver disease;
[0026] The neurodegenerative disease is Alzheimer's disease.
[0027] Furthermore, the present invention provides an antioxidant stress preparation that acts on Caenorhabditis elegans with Alzheimer's mutations to prolong the lifespan of Caenorhabditis elegans, inhibit the production of lipofuscin in Caenorhabditis elegans, eliminate ROS in Caenorhabditis elegans, enhance the activity of antioxidant enzymes in Caenorhabditis elegans, and alleviate neurotoxicity, indicating that the antioxidant stress preparation described in the present invention can be used for the prevention or treatment of Alzheimer's disease.
[0028] Furthermore, the present invention provides an antioxidant stress preparation for the treatment of Caenorhabditis elegans induced by a high-fat diet. The antioxidant stress preparation of the present invention has a positive effect on extending the lifespan, reducing fat accumulation, reducing the level of non-esterified fatty acids, increasing the activity of antioxidant enzymes, and reducing the content of malondialdehyde in Caenorhabditis elegans fed a high-fat diet, indicating that the antioxidant stress preparation of the present invention can be used for the prevention or treatment of liver diseases.
[0029] Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects or advantages:
[0030] The present invention proposes a strategy for effectively preventing and treating neurodegenerative diseases and liver diseases related to oxidative stress from the perspective of synergistic anti-oxidative stress, based on the two-way communication between the intestine and major organs such as the brain, liver, and heart mediated by intestinal probiotics. Specifically, the present invention obtains an anti-oxidative stress preparation by mixing active bovine milk exosomes loaded with antioxidant ingredients, microalgae, probiotics, and cationic polysaccharides. The preparation extended the average lifespan of N2-type Caenorhabditis elegans by 69.81%, the median lifespan by 66.67%, and the maximum lifespan by 45.45%. It also reduced the aging marker lipofuscin by 45.94%, which can significantly delay the normal aging rhythm. At the same time, the preparation can significantly extend the average lifespan, median lifespan and maximum lifespan of the Alzheimer's mutant (CL4176 type) of N2-type Caenorhabditis elegans. While reducing the lipofuscin content, it can also increase the activity of antioxidant enzymes including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px), and can significantly reduce the content of lipid peroxidation product malondialdehyde (MDA) by 84.77%, indicating that the preparation can prevent and treat Alzheimer's disease by resisting oxidative stress. In addition, under high sugar induction, the preparation significantly extended the lifespan of glucose-induced N2 nematodes while increasing the activity of antioxidant enzymes in the body and reducing the content of MDA. In addition, under the intervention of this preparation, not only the lifespan of the N2 type Caenorhabditis elegans high glucose model was significantly prolonged, but also the triglyceride (TG) and non-esterified fatty acid (NEFA) content in the glucose-induced N2 nematodes was significantly reduced, indicating that this anti-oxidative stress preparation has significant blood sugar and lipid-lowering effects.
[0031] In summary, the preparation can be used as a food, food additive or drug to remove excess free radicals in the body, enhance the activity of antioxidant enzymes, and reduce the content of lipid peroxidation products through anti-oxidative stress, thereby achieving efficient prevention and treatment of neurodegenerative diseases and liver diseases related to oxidative stress. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 This is the Zeta potential diagram of anti-oxidative stress functional foods.
[0033] Figure 2 The microscopic morphology of anti-oxidative stress functional foods. Among them, (A) is milk exosomes; (B) is active exosomes; (C) is spirulina; (D) is lactic acid bacteria; (E) is functional food 1; (F) is a mixture.
[0034] Figure 3 The survival rate curve of C. elegans after different treatments. Among them, (A) is N2 type C. elegans; (B) is CL4176 type C. elegans.
[0035] Figure 4This is the fluorescence image of lipofuscin in N2 type Caenorhabditis elegans after 10 days of different treatments.
[0036] Among them, (A) is the lipofuscin content of the blank group; (B) is the lipofuscin content of the spirulina group; (C) is the lipofuscin content of the active exosome group; (D) is the lipofuscin content of the milk exosome group; (E) is the lipofuscin content of the schisandrin B group; (F) is the lipofuscin content of the functional food 1 group; (G) is the lipofuscin fluorescence intensity diagram in the N2 type Caenorhabditis elegans.
[0037] Figure 5 The lipofuscin fluorescence images of CL4176 Caenorhabditis elegans after 10 days of different treatments. Among them, (A) is the lipofuscin content of the blank group; (B) is the lipofuscin content of the spirulina group; (C) is the lipofuscin content of the active exosome group; (D) is the lipofuscin content of the milk exosome group; (E) is the lipofuscin content of the schisandrin B group; (F) is the lipofuscin content of the functional food 1 group; (G) is the lipofuscin fluorescence intensity image of CL4176 Caenorhabditis elegans.
[0038] Figure 6 This is a fluorescence image of ROS in N2 type Caenorhabditis elegans after 10 days of different treatments.
[0039] Among them, (A) is the ROS fluorescence image of the blank group treatment; (B) is the ROS fluorescence image of the Spirulina treatment; (C) is the ROS fluorescence image of the active exosome treatment; (D) is the ROS fluorescence image of the milk exosome treatment; (E) is the ROS fluorescence image of the Schisandrin B treatment; (F) is the ROS fluorescence image of the functional food 1 treatment; (G) is the ROS fluorescence intensity image in the N2 type Caenorhabditis elegans.
[0040] Figure 7 The fluorescence images of ROS in CL4176 Caenorhabditis elegans after different treatments for 10 days. Among them, (A) is the ROS fluorescence image of the blank group; (B) is the ROS fluorescence image of the spirulina treatment; (C) is the ROS fluorescence image of the active exosome treatment; (D) is the ROS fluorescence image of the milk exosome treatment; (E) is the ROS fluorescence image of the schisandrin B treatment; (F) is the ROS fluorescence image of the functional food 1 treatment; (G) is the ROS fluorescence intensity image in CL4176 Caenorhabditis elegans.
[0041] Figure 8The changes in antioxidant enzyme activities in C. elegans after different treatments. Among them, (A) is the SOD activity in N2-type C. elegans; (B) is the CAT activity in N2-type C. elegans; (C) is the GSH-Px activity in N2-type C. elegans; (D) is the MDA content in N2-type C. elegans; (E) is the SOD activity in CL4176-type C. elegans; (F) is the CAT activity in CL4176-type C. elegans; (G) is the GSH-Px activity in CL4176-type C. elegans; (H) is the MDA content in CL4176-type C. elegans.
[0042] Fig. 9 This is a survival curve of high-fat-induced N2-type Caenorhabditis elegans after different treatments.
[0043] Fig.10 Figure 3 is the triglyceride content in N2 nematodes induced by high fat after different treatments.
[0044] Fig.11 The non-esterified fatty acid content in N2 nematodes induced by high fat in different treatments.
[0045] Fig.12 Figure 4 shows the CAT enzyme activity in N2-type Caenorhabditis elegans induced by high fat in different treatments.
[0046] Fig.13 The SOD enzyme activity in N2-type Caenorhabditis elegans induced by high fat in different treatments.
[0047] Fig.14 The GSH-Px enzyme activity in N2-type Caenorhabditis elegans induced by high fat in different treatments.
[0048] Fig.15 The MDA content in high-fat-induced N2-type Caenorhabditis elegans after different treatments. DETAILED DESCRIPTION
[0049] The technical scheme of the present invention is described below in conjunction with the embodiments, but the present invention is not limited to the following embodiments. The experimental methods and detection methods described in each embodiment are conventional methods unless otherwise specified; the reagents and materials described are all commercially available unless otherwise specified.
[0050] Example 1
[0051] This embodiment provides a method for preparing an antioxidant stress preparation.
[0052] 1. Preparation of active exosomes
[0053] Fresh milk stored at low temperature was divided into centrifuge tubes and centrifuged at low temperature to obtain skimmed milk. The pH of the skimmed milk was adjusted to about 4.6 with hydrochloric acid (2M). Centrifuged at low temperature again to obtain a whey solution, which was filtered to remove residual protein. Centrifuged again at low temperature in an ultra-high-speed refrigerated centrifuge to obtain a yellow colloidal precipitate. After washing the precipitate three times with pre-cooled PBS solution, the exosomes were dispersed in PBS and stored in a -20°C refrigerator for later use. Take 2mL of the milk exosome solution and dilute it to 10mL, and mix it with 10mL and 5mg·mL -1 The ethanol solution of Schisandrin B was mixed evenly and stirred at room temperature for 24 hours, and then dialyzed to remove the unencapsulated Schisandrin B, thereby obtaining the milk exosomes encapsulating Schisandrin B, referred to as active exosomes.
[0054] 2. Preparation of functional food 1 for anti-oxidative stress
[0055] 20 mL of active exosomes (5 μg mL -1 ), 90 mg of spirulina and 100 mg of chitosan were mixed thoroughly, and then 10 mg of lactic acid bacteria was added to make the lactic acid bacteria reach 1×10 10 CFU·mL -1 , mixed for 24 hours and then dried to obtain an antioxidant stress preparation, which was recorded as functional food 1.
[0056] 3. Preparation of mixture
[0057] 20 mL of active exosomes (5 μg mL -1 ), 90 mg of spirulina and 100 mg of chitosan were mixed thoroughly, and then 10 mg of lactic acid bacteria was added to make the lactic acid bacteria reach 1×10 10 CFU·mL -1 , the samples that were directly dried without mixing for 24 h were regarded as physical mixtures (referred to as mixtures, as the control group).
[0058] 4. Preparation of functional food 1 for anti-oxidative stress
[0059] 20 mL of active exosomes (5 μg mL -1 ), 45 mg of spirulina and 100 mg of chitosan were mixed thoroughly, and then 55 mg of lactic acid bacteria were added to make the lactic acid bacteria reach 1×10 10 CFU·mL -1 , mixed for 24 hours and then dried to obtain an antioxidant stress preparation, which was recorded as functional food 2.
[0060] Example 2
[0061] This example provides the zeta potential of an anti-oxidative stress agent.
[0062] The Zeta potential of milk exosomes, active exosomes, chitosan, lactic acid bacteria and the functional food prepared in Example 1 was measured using a Zeta potential instrument.
[0063] like Figure 1 As shown, the Zeta potential of bovine milk exosomes, active exosomes, and lactic acid bacteria were 5.29±0.8mV, -26.93±0.39mV, and -10.72±0.53mV, respectively; the Zeta potential of chitosan was 20.25±1.33mV. After interacting with chitosan active exosomes and lactic acid bacteria to form functional foods 1 and 2, their Zeta potentials decreased to 5.42±0.18mV and 5.28±0.02mV, respectively, confirming that functional foods 1 and 2 were successfully prepared.
[0064] Example 3
[0065] This example provides a microscopic picture of the anti-oxidative stress preparation.
[0066] The dispersion of milk exosomes and active exosomes (10 μL) was added to the copper mesh, dried at room temperature, and then negatively stained with 2% phosphotungstic acid. After the negative staining, the copper mesh was gently washed 5 to 6 times in distilled water droplets and left to dry at room temperature. Under room temperature, the microscopic morphology of milk exosomes and active exosomes was observed under a transmission electron microscope at an accelerating voltage of 80 kV. The microscopic morphology of spirulina, lactic acid bacteria, functional food 1 and the mixture was observed using a scanning electron microscope. The operation method is as follows: pre-paste conductive glue on the sample stage, take an appropriate amount of dry spirulina powder, lactic acid bacteria, functional food 1 and the mixture and stick them on the conductive glue, blow off the excess sample with an ear wash bulb and spray gold. The microscopic morphology of spirulina, lactic acid bacteria, functional food 1 and the mixture was observed using a scanning electron microscope.
[0067] like Figure 2 As shown in (A), the milk exosomes are spherical structures with a particle size of 204.48±3.57nm. After embedding Schisandrin B, a large number of nanoscale black dots appeared in the active exosomes (such as Figure 2 As shown in (B), this is formed after the hydrophobic Schisandrin B aggregates. Compared with the milk exosomes, the particle size of the active exosomes increased to 1449.64±102.35nm, which proves the successful loading of Schisandrin B. Figure 2 As shown in (C), Spirulina has a spiral structure with a diameter of 3 to 5 μm. Figure 2 (D) in the figure is the microstructure of the lactic acid bacteria after freeze-drying. It can be clearly seen that the lactic acid bacteria present a curled lamellar structure. This lays the structural foundation for the subsequent interaction with chitosan. Figure 2In (E), it can be found that functional food 1 presents a three-dimensional framework structure with a pore size of 10 to 60 μm composed of lamellar lactic acid bacteria, spirulina and chitosan, and nano-scale active exosomes (nanospheres) are embedded in the three-dimensional framework structure. When chitosan, schisandrin B, spirulina and active exosomes have not interacted in the solution for 24 hours, they have not been assembled to form a special structure, and the above components are randomly distributed in the SEM field of view ( Figure 2 (F) in the figure.
[0068] Example 4
[0069] This example provides information on the extension of the lifespan of Caenorhabditis elegans after the anti-oxidative stress agent is applied to it.
[0070] The Caenorhabditis elegans in this embodiment is divided into N2 type and CL4176 type, both of which feed on Escherichia coli OP50. The culture medium (NGM) for the growth of Caenorhabditis elegans is placed in a biochemical incubator at 20°C. After synchronizing the Caenorhabditis elegans, the Caenorhabditis elegans is fully lysed. The Caenorhabditis elegans is centrifuged at 4000r / min for 2min, and then washed twice with M9 buffer, and the collected precipitate is the Caenorhabditis elegans egg. Finally, the Caenorhabditis elegans eggs are transferred to the NGM culture medium covered with OP50, and the L1 stage Caenorhabditis elegans larvae are obtained after culturing at 20°C for 24h, and the L4 stage Caenorhabditis elegans adults are obtained after about 48 to 72h.
[0071] The L4-stage Caenorhabditis elegans were transferred to the functional food 1 (15 mg mL -1 )、Functional food 2(15mg·mL -1 )、Spirulina (4.8mg·mL -1 ), Schisandrin B (2 μg·mL -1 ), active exosomes (0.1 mg mL -1 ), milk exosomes (30 μL), mixture (15 mg mL -1 ) in a 24-well plate, and add 1 mL of PBS buffer, 10 μL of 5-fluorouracil (1.25 mg mL -1 ). This time is recorded as the 0th day of the experiment, and the plates are turned every two days. When the C. elegans does not respond to the touch of the pick, it is considered dead. During this process, the number of deaths is observed and recorded until all the tested C. elegans die, and the survival curve of C. elegans is drawn. The experiment is repeated three times, and the calculation formula is as follows:
[0072]
[0073] like Figure 3As shown in (A), the average lifespan of N2 type Caenorhabditis elegans exposed to schisandrin B, Spirulina, milk exosomes, active exosomes, functional food 1, functional food 2 and the mixture was 10.13±0.89 days, 16.00±0.83 days, 13.27±0.68 days, 13.20±0.75 days, 17.40±0.48 days, 18.93±0.33 days and 15.20±0.64 days, respectively. In addition, compared with the blank group (untreated N2 type Caenorhabditis elegans), the lifespan of N2 type Caenorhabditis elegans was increased. The maximum lifespan of N2 type Caenorhabditis elegans treated with schisandrin B, spirulina, milk exosomes, active exosomes, functional food 1, and functional food 2 were 24.00±1.37 days, 26.00±2.24 days, 24.00±1.67 days, 24.00±3.36 days, 32.00±2.84 days, and 32.00±2.11 days, respectively, which were 9.09%, 18.18%, 9.09%, 9.09%, 45.45%, and 45.45% longer than those in the blank group (Table 1). However, the mixture can only extend the lifespan of N2 type Caenorhabditis elegans to 24.00±2.24 days, but the extension is similar to that of bovine milk exosomes, indicating that when active exosomes, spirulina, chitosan, and lactic acid bacteria are simply mixed, their effect on extending the lifespan of N2 type Caenorhabditis elegans is not as good as functional food 1 and functional food 2 that interact to form a three-dimensional framework structure.
[0074] Table 1 Lifespan and its change rate of N2-type Caenorhabditis elegans
[0075] sample Average life span (d) Median life span (d) Maximum lifespan (d) Rate of change (%) Significance analysis blank 10.60±0.64 12.00±0.65 22.00±1.98 - na Schisandrin B 10.13±0.89 14.00±1.29 24.00±1.37 9.09%↑ ns Spirulina 16.00±0.83 17.00±1.91 26.00±2.24 18.18%↑ 0.0009,*** milk exosomes 13.27±0.68 16.00±1.08 24.00±1.67 9.09%↑ 0.0077,** active exosomes 13.20±0.75 16.00±1.58 24.00±3.36 9.09%↑ 0.0103,* Functional Food1 17.40±0.48 20.00±0.84 32.00±2.84 45.45%↑ 0.0001,*** Functional Food 2 18.93±0.33 20.00±1.25 32.00±2.11 45.45%↑ 0.0003,*** mixture 15.20±0.64 16.00±1.17 24.00±2.24 9.09%↑ 0.0043,**
[0076] like Figure 2As shown in (B), the average lifespan of CL4176 Caenorhabditis elegans exposed to schisandrin B, spirulina, milk exosomes, active exosomes, functional food 1, functional food 2 and the mixture was 12.07±2.87 days, 14.73±1.46 days, 10.93±2.62 days, 15.20±1.14 days, 17.40±1.27 days, 18.86±2.23 days and 15.00±1.22 days, respectively, and the average lifespan of Caenorhabditis elegans in the blank group was 9.73±0.33 days. The longest lifespan of the above groups of Caenorhabditis elegans were 22.00±1.29 days, 24.00±2.27 days, 22.00±1.64 days, 24.00±0.88 days, 30.00±3.79 days and 30.00±2.84 days, respectively, which were extended by 22.22%, 33.33%, 22.22%, 33.33%, 66.67% and 66.67% respectively compared with the blank group. The extension of the mixture was similar to that of bovine milk exosomes, which could only extend the lifespan of Caenorhabditis elegans to 22.00±3.21 days (Table 2), which once again confirmed the biosafety of functional foods and their very positive effect in extending the lifespan of Caenorhabditis elegans with Alzheimer's mutations. In particular, the lifespan of the CL4176 type Caenorhabditis elegans model can be restored to the same level as N2 after being treated with functional food 1 and functional food 2, confirming its great potential for extending the lifespan of Alzheimer's mutant Caenorhabditis elegans.
[0077] Table 2 Lifespan and its change rate of CL4176 Caenorhabditis elegans
[0078] sample Average life span (d) Median life span (d) Maximum lifespan (d) Rate of change (%) Significance analysis blank 9.73±0.33 12.00±1.77 18.00±1.45 - na Schisandrin B 12.07±2.87 14.00±0.87 22.00±1.29 22.22%↑ ns Spirulina 14.73±1.46 18.00±2.82 24.00±2.27 33.33%↑ 0.0044,** milk exosomes 10.93±2.62 13.00±3.41 22.00±1.64 22.22%↑ ns active exosomes 15.20±1.14 16.00±1.88 24.00±0.88 33.33%↑ 0.0013,** Functional Food1 17.40±1.27 20.00±2.79 30.00±3.79 66.67%↑ 0.0005,*** Functional Food 2 18.86±2.23 20.00±1.74 30.00±2.84 66.67%↑ 0.0022,** mixture 15.00±1.22 16.00±2.12 22.00±3.21 22.22%↑ ns
[0079] Example 5
[0080] This example provides the content of lipofuscin in Caenorhabditis elegans after the antioxidant stress preparation acts on it.
[0081] The synchronized Caenorhabditis elegans were cultured in NGM plates containing schisandrin B, spirulina, milk exosomes, and active exosome functional food 1 for 10 days, and fixed after anesthesia with 10mM tetramisole hydrochloride. Twenty randomly selected Caenorhabditis elegans in each group were photographed under a fluorescence microscope with an excitation wavelength of 380nm and an emission wavelength of 430nm. ImageJ was used to analyze the fluorescence intensity of lipofuscin in Caenorhabditis elegans to reflect the lipofuscin content in Caenorhabditis elegans.
[0082] As the body ages, the balance of cellular metabolism is disturbed, leading to a large accumulation of free radicals. These free radicals may react with unsaturated fatty acids to form lipofuscin, a pigmentation phenomenon associated with age. In short, the higher the fluorescence intensity of lipofuscin, the more obvious the aging of C. elegans.
[0083] Figure 4 (A) is the lipofuscin fluorescence image of untreated N2-type Caenorhabditis elegans after 10 days (blank group). Figure 4 (B) is the lipofuscin fluorescence image of N2 type Caenorhabditis elegans treated with Spirulina after 10 days. Figure 4 (C) is the lipofuscin fluorescence image of N2 type Caenorhabditis elegans treated with active exosomes after 10 days. Figure 4 (D) is the lipofuscin fluorescence image of N2 type Caenorhabditis elegans treated with milk exosomes 10 days later. Figure 4 (E) is the lipofuscin fluorescence image of N2 type Caenorhabditis elegans treated with schisandrin B after 10 days. Figure 4 (F) in the middle is the lipofuscin fluorescence image of N2 type Caenorhabditis elegans treated with functional food 1 after 10 days. Figure 5 (A) is the lipofuscin fluorescence image of untreated CL4176 Caenorhabditis elegans after 10 days (blank group). Figure 5 (B) is the fluorescence image of lipofuscin in CL4176 type Caenorhabditis elegans treated with Spirulina after 10 days. Figure 5 (C) is the lipofuscin fluorescence image of CL4176 Caenorhabditis elegans treated with active exosomes after 10 days. Figure 5 (D) is the lipofuscin fluorescence image of CL4176 Caenorhabditis elegans treated with milk exosomes 10 days later. Figure 5 (E) is the fluorescence image of lipofuscin in CL4176 type Caenorhabditis elegans treated with schisandrin B after 10 days. Figure 5 (F) is the fluorescence image of lipofuscin in CL4176 type Caenorhabditis elegans treated with functional food 1 after 10 days. Figure 4 and Figure 5 It was found that the overall lipofuscin level of N2 type Caenorhabditis elegans was lower than that of CL4176. Functional food 1 and its various components all have the effect of alleviating the aging of Caenorhabditis elegans.
[0084] Depend on Figure 5 (A-F) It can be seen that the lipofuscin content in Caenorhabditis elegans is in the following order from high to low: blank > milk exosomes > spirulina > active exosomes > schisandrin B > functional food 1; Figure 4Figure (G) in and Figure (G) in 5 show that the lipofuscin content in N2 type Caenorhabditis elegans and CL4176 Caenorhabditis elegans intervened by functional food 1 is the lowest, confirming that functional food can significantly inhibit the production of lipofuscin in Caenorhabditis elegans with Alzheimer's mutation, thereby delaying the aging rhythm of Caenorhabditis elegans.
[0085] Example 6
[0086] This example provides the endogenous ROS level in Caenorhabditis elegans after the anti-oxidative stress preparation acts on it.
[0087] During the experiment, the Caenorhabditis elegans used in the experiment were first carefully cleaned to ensure that their surface was clean. Subsequently, the fluorescent labeling reagent DCFA-DH (50 μM) was evenly distributed to each independent unit of the 24-well plate, and 1 mL of the solution was injected into each well. The treated Caenorhabditis elegans were transferred to the independent unit of the 24-well plate, the wells were closed to avoid light interference, and dark-adapted culture was carried out in a 20°C incubator for 1 hour. In order to eliminate the fluorescent dye that may remain on the Caenorhabditis elegans, after completing the above steps, M9 buffer was used for three washes again. The washed Caenorhabditis elegans were placed in a centrifuge tube, and 1 mL of 60 μM levamisole anesthetic was taken and mixed with the Caenorhabditis elegans liquid. Subsequently, the mixed solution containing anesthetized Caenorhabditis elegans was dropped onto a special slide to form the required sample. Finally, the sample was sent to a laser confocal fluorescence microscope to capture clear fluorescence images at an excitation wavelength of 485 nm. Twenty Caenorhabditis elegans were randomly selected from each group for photography, and the relative fluorescence intensity was analyzed using ImageJ software.
[0088] During the natural aging process, the body continuously generates reactive oxygen species (ROS), which have strong oxidative effects and are considered to be one of the key factors leading to aging. In this example, the endogenous ROS level in Caenorhabditis elegans was monitored by using the DCFH-DA fluorescent probe method. The fluorescence intensity was positively correlated with the ROS content. Therefore, the ROS content in Caenorhabditis elegans was evaluated by the fluorescence intensity, thereby evaluating the potential regulatory effect of antioxidant preparations on its oxidative stress state. Figure 6 (A) is the ROS fluorescence image of the untreated N2 type Caenorhabditis elegans after 10 days (blank group). Figure 6 (B) is the ROS fluorescence image of N2 type Caenorhabditis elegans treated with Spirulina after 10 days. Figure 6 (C) is the ROS fluorescence image of N2 type Caenorhabditis elegans treated with active exosomes after 10 days. Figure 6 (D) is the ROS fluorescence image of N2 type Caenorhabditis elegans treated with milk exosomes after 10 days. Figure 6(E) is the ROS fluorescence image of N2 type Caenorhabditis elegans treated with Schisandrin B after 10 days. Figure 6 (F) is a fluorescence image of ROS in N2 C. elegans treated with functional food 1 after 10 days. The level of ROS in N2 C. elegans was quantified by ImageJ software. Functional food 1 and its components all had significant scavenging effects on ROS, among which functional food 1 had the most obvious scavenging effect on ROS (e.g. Figure 6 (G) in the figure further confirms the great potential of functional foods in resisting oxidative stress.
[0089] Figure 7 (A) is the ROS fluorescence image of untreated CL4176 Caenorhabditis elegans after 10 days (blank group). Figure 7 (B) is the ROS fluorescence image of N2 type Caenorhabditis elegans treated with Spirulina after 10 days. Figure 7 (C) is the ROS fluorescence image of CL4176 type Caenorhabditis elegans treated with active exosomes after 10 days. Figure 7 (D) is the ROS fluorescence image of CL4176 type Caenorhabditis elegans treated with milk exosomes after 10 days. Figure 7 (E) is the ROS fluorescence image of CL4176 type Caenorhabditis elegans treated with Schisandrin B after 10 days. Figure 7 (F) is the ROS fluorescence image of CL4176 C. elegans treated with functional food 1 after 10 days. The ROS content in CL4176 C. elegans is from high to low: blank group > Schisandrin B > exosomes > Spirulina > active exosomes > functional food 1. By comparison, it was found that the fluorescence intensity of CL4176 C. elegans in the functional food 1 group was the weakest ( Figure 7 (G) in the figure indicates that the ROS content in the CL4176 type of Caenorhabditis elegans in this group is the lowest, which not only confirms the biosafety of functional food 1, but also further confirms its ability to scavenge ROS.
[0090] Example 7
[0091] This example provides the changes in antioxidant enzyme activities in Caenorhabditis elegans after the antioxidant stress preparation acts on the nematode.
[0092] The synchronized L1-stage Caenorhabditis elegans were exposed under the same conditions. The experiment was terminated after 10 days. The treated Caenorhabditis elegans were collected and washed in M9 buffer three times in a row to ensure their cleanliness. Subsequently, the treated Caenorhabditis elegans were transferred to a pre-sterilized centrifuge tube, and 2 mL of PBS buffer was added to each tube, and two sterilized steel balls were added as grinding aids. The vortex lasted for 30 seconds each time, with an interval of 20 seconds, for a total of three times, to fully break and evenly grind the Caenorhabditis elegans. This process was always maintained at a low temperature to protect the protein structure. Centrifuge at 8000r / min for 10 minutes. After completing this process, the supernatant was transferred to a new centrifuge tube for subsequent total protein content determination. SOD, CAT, GSH-Px activity and MDA content were calculated by measuring the optical density. Each determination was repeated three times.
[0093] SOD can separate superoxide anions into H 2 O 2 and O 2 CAT can convert H 2 O 2 Decomposed into H 2 O and O 2 As an important non-enzymatic antioxidant, GSH-Px exists inside cells. It produces more reduced glutathione (GSH) under the catalysis of GSH-Px. GSH reduces H 2 O 2 At the same time, GSH is oxidized to oxidized glutathione (GSSG), which is catalyzed by GSH-Px to generate GSH again. Through this reaction, GSH accumulates, which can remove oxygen ions and other free radicals in the body, delay the aging of the body, and effectively activate the antioxidant defense mechanism in the nematode.
[0094] Figure 8 (A) is the SOD activity in N2-type Caenorhabditis elegans. Figure 8 (B) shows the CAT activity in N2-type Caenorhabditis elegans. Figure 8 (C) in the figure shows the GSH-Px activity in N2-type Caenorhabditis elegans. Figure 8 (E) in the figure is the SOD activity in CL4176 type Caenorhabditis elegans. Figure 8 (F) in the figure is the CAT activity in CL4176 type Caenorhabditis elegans. Figure 8The (G) in the figure is the GSH-Px activity in CL4176 C. elegans, as well as the changes in the antioxidant enzyme activities in N2 C. elegans in Table 3 and the changes in the antioxidant enzyme activities in CL4176 C. elegans in Table 4. Functional food 1 and its components have different degrees of improvement on the antioxidant enzyme activities in N2 and CL4176 C. elegans, especially functional food 1. Specifically, MDA is one of the end products of cellular lipid peroxidation and is often used as an important indicator to measure the degree of lipid oxidation, reflecting the level of intracellular oxidative damage. After treatment with functional food 1, the MDA content in N2 and CL4176 C. elegans was 1.84±0.46nmol / mgprot and 4.52±0.70nmol / mgprot, respectively.
[0095] Figure 8 (D) in the figure is the MDA content in N2-type Caenorhabditis elegans. Figure 8 As shown in (A~D) and Table 3, compared with the blank group, the SOD activity of N2 type Caenorhabditis elegans exposed to functional food 1 was significantly increased by 441.93%, the CAT activity was significantly increased by 261%, the GSH-Px activity was increased by 258.97%, and the MDA content was reduced by 88.25%, indicating that functional food 1 can prolong the lifespan of normal Caenorhabditis elegans through anti-oxidation, confirming its prospect of being developed as functional food 1.
[0096] Figure 8 (H) in the figure is the MDA content in CL4176 C. elegans. Figure 8 As shown in (E~H) and Table 4, after exposure to functional food 1, the SOD enzyme activity of CL4176 Caenorhabditis elegans increased by 144.34%, the CAT enzyme activity increased by 72.30%, the GSH-Px activity increased by 612.39%, and the MDA content decreased by 84.63% compared with the blank group.
[0097] Table 3 Changes in antioxidant enzyme activities in N2-type Caenorhabditis elegans
[0098]
[0099] Table 4 Changes in antioxidant enzyme activities in CL4176 Caenorhabditis elegans
[0100]
[0101] The functional food 1 increases the activity of antioxidant enzymes, reduces the content of MDA to resist oxidative stress, and delays the aging of the body, thereby effectively activating the antioxidant defense mechanism in the body of Caenorhabditis elegans, alleviating neurotoxicity, and thereby prolonging the lifespan of Caenorhabditis elegans. The above results also prove that the antioxidant stress food described in the present invention can be used for the prevention or treatment of Alzheimer's disease.
[0102] Example 8
[0103] This example provides information on the lifespan extension of high-fat Caenorhabditis elegans after different treatments.
[0104] The adult Caenorhabditis elegans of the L4 stage in Example 4 was taken. The Caenorhabditis elegans was placed in a high-fat (HF) feeding environment and cultured on an NGM plate containing Escherichia coli OP50 and 10 mM glucose for 5 days to obtain high-fat Caenorhabditis elegans. Then, the high-fat Caenorhabditis elegans were transferred to a culture medium containing no antioxidant stress ingredients (blank group) and a culture medium containing functional food 1 (15 mg mL -1 )、Spirulina (4.8mg·mL -1 ), Schisandrin B (2 μg·mL -1 ), active exosomes (0.1 mg mL -1 elegans in a 24-well plate containing 2% (0.1% ) and bovine milk exosomes (30 μL) for 48 h, and lifespan analysis was performed.
[0105] like Fig. 9 As shown in the results, after high-fat diet induction, schisandrin B, spirulina, and active exosomes can prolong the average, median, and maximum lifespan of high-fat Caenorhabditis elegans, and functional food 1 has the most significant effect on the lifespan of N2 Caenorhabditis elegans induced by high-fat diet. Among them, compared with the blank group of Caenorhabditis elegans, the maximum lifespan of schisandrin B, spirulina, active exosomes, and functional food 1 groups was extended by 10%, 10%, 20%, 20%, and 60%, respectively (Table 5), indicating that functional food 1 has a beneficial effect on prolonging the lifespan of high-sugar diet Caenorhabditis elegans.
[0106] Table 5 Lifespan and its change rate of N2 type Caenorhabditis elegans after high-fat induction
[0107]
[0108]
[0109] Example 9
[0110] This example provides the activities of antioxidant enzymes in high-fat Caenorhabditis elegans after different treatments.
[0111] The L4-stage Caenorhabditis elegans adults after different treatments in Example 8 were washed three times with M9 buffer and further sonicated. The levels of triglycerides (TG), non-esterified fatty acids (NEFA), CAT, SOD, GSH-Px and MDA in the Caenorhabditis elegans of the above-mentioned treatment groups were determined using the corresponding kits.
[0112] Non-esterified fatty acids (NEFA) are the product of neutral fat metabolism, and excess NEFA will produce free radicals. Free radicals can react with the lipid bilayer of the cell membrane and cause lipid peroxidation. This process damages the cell membrane, leading to cell dysfunction, which may affect the health of liver cells. A large amount of evidence shows that excessive NEFA can lead to metabolic disorders such as obesity and hyperlipidemia. When fat intake exceeds the body's needs, excess NEFA will accumulate in the liver and be converted into triglycerides (TG) for storage. If this state persists, it may lead to increased TG levels in the liver and the formation of fatty liver. Therefore, TG levels can be used as a marker of fat accumulation, and monitoring NEFA and TG levels is of certain significance for the prevention and treatment of liver disease.
[0113] Depend on Fig.10 It can be seen that the TG content of C. elegans treated with functional food 1 and fed with a high-fat diet was 43.24% lower than that of C. elegans in the blank group, which indicates that functional food 1 can improve the fat accumulation of TG in C. elegans. In addition, the NEFA level of C. elegans under each treatment condition was also evaluated. Fig.11 As shown in Figure 1, NEFA levels increased significantly with a high-fat diet, and feeding functional food 1 and its individual components could effectively reduce NEFA levels, which was consistent with the TG results. Specifically, compared with C. elegans fed a high-fat diet (blank), the NEFA content of C. elegans was reduced by 40% after intervention with functional food 1. Therefore, functional food 1 showed a significant ability to alleviate fat accumulation and reduce NEFA levels in high-fat C. elegans.
[0114] Fig.12 is the CAT level of high-fat Caenorhabditis elegans after different treatments. Fig.13 is the SOD level of high-fat Caenorhabditis elegans after different treatments. Fig.14The GSH-Px levels of high-fat Caenorhabditis elegans after different treatments. After high-fat culture, the activities of CAT, SOD and GSH-Px of Caenorhabditis elegans decreased. Through the intervention of functional food 1, the activities of CAT, SOD and GSH-Px antioxidant enzymes were all improved. After the intervention of functional food 1, the CAT, SOD and GSH-Px activities of high-fat diet Caenorhabditis elegans increased by 245.45%, 184.38% and 625%, respectively. These results indicate that the functional food 1 can increase the activity of antioxidant enzymes in Caenorhabditis elegans exposed to a high-fat diet. MDA is a key biomarker that can reflect the rate of organ lipid peroxidation and the intensity of peroxidative damage. Fig.15 As shown, after feeding functional food 1 to C. elegans on a high-fat diet, the MDA content of C. elegans decreased by 78.64%, verifying that functional food 1 can greatly reduce the MDA content of C. elegans in a high-fat environment. The above results show that
[0115] The embodiments described above are part of the embodiments of the present invention, but not all of them. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but only represents selected embodiments of the present invention. All other embodiments obtained without creative work and related deductions and substitutions made by ordinary technicians in the field under the conditions of the concept of the present invention belong to the scope of protection of the present invention.
Claims
1. An anti-oxidative stress preparation, characterized in that It is composed of inner nanospheres and outer three-dimensional framework; The nanospheres are made of milk exosomes encapsulating schisandra chinensis B to form active exosomes; The three-dimensional framework is formed by the interaction and connection of lactic acid bacteria, spirulina and chitosan.
2. The anti-oxidative stress preparation according to claim 1, characterized in that The particle size of the active exosomes is 1449.64±102.35nm; The three-dimensional framework is a three-dimensional structure with a pore size of 10 to 60 μm.
3. A method for preparing an antioxidant stress preparation, characterized in that: The steps include: (1) Preparation of milk exosomes: fresh milk is centrifuged at low temperature to obtain skim milk; after adjusting the pH of the skim milk, it is centrifuged at low temperature to obtain a whey solution; The whey solution was filtered and centrifuged at low temperature to obtain a yellow colloidal precipitate; The yellow colloidal precipitate was washed with PBS solution and dispersed in PBS solution, and the obtained milk exosomes were stored for future use; (2) Preparation of active exosomes: The milk exosomes were diluted and mixed with an ethanol solution containing schisandrin B to remove unencapsulated schisandrin B and obtain active exosomes; (3) After the active exosomes, spirulina, and chitosan are completely mixed, lactic acid bacteria are added and mixed to react to prepare an antioxidant stress preparation.
4. The preparation method according to claim 3, characterized in that: In the step (1), the pH of the skim milk is adjusted to 4.6 with 2M hydrochloric acid; In step (1), the storage temperature of the milk exosomes is -20°C; The dilution of the bovine milk exosomes in step (2) is as follows: 2 mL of the bovine milk exosomes in step (1) is diluted to 10 mL; The volume of the ethanol solution containing schisandrin B in step (2) is 10 mL, and the concentration of the ethanol solution containing schisandrin B is 5 mg·mL -1 ; The mixing reaction time in step (2) is 24 hours.
5. The preparation method according to claim 3, characterized in that: The volume of active exosomes in step (3) is 20 mL, and the concentration of active exosomes is 5 μg·mL -1 ; The mass of the spirulina is 45 to 90 mg; The mass of the chitosan is 100 mg; The mass of the lactic acid bacteria is 10 to 55 mg.
6. The preparation method according to claim 5, characterized in that: The volume of the active exosomes is 20 mL, and the concentration of the active exosomes is 5 μg·mL -1 ; The mass of the spirulina is 90 mg; The mass of the chitosan is 100 mg; The mass of the lactic acid bacteria is 10 mg.
7. The preparation method according to any one of claims 5 to 6, characterized in that: The final concentration of lactic acid bacteria was 1×10 10 CFU·mL -1 .
8. Use of the antioxidant stress preparation according to any one of claims 1 to 2, or the preparation method according to any one of claims 3 to 7, in preparing food having the following effects, characterized in that: The utility includes: preventing or treating diseases caused by oxidative stress; The disease comprises at least one of a neurodegenerative disease and a liver disease; The neurodegenerative disease is Alzheimer's disease.
9. Use of the antioxidant stress preparation according to any one of claims 1 to 2, or the preparation method according to any one of claims 3 to 7, in the preparation of a food additive having the following effects, characterized in that: The utility includes: preventing or treating diseases caused by oxidative stress; The disease comprises at least one of a neurodegenerative disease and a liver disease; The neurodegenerative disease is Alzheimer's disease.
10. Use of the anti-oxidative stress preparation according to any one of claims 1 to 2, or the preparation method according to any one of claims 3 to 7, in the preparation of a drug having the following effects, characterized in that: The utility includes: preventing or treating diseases caused by oxidative stress; The disease comprises at least one of a neurodegenerative disease and a liver disease; The neurodegenerative disease is Alzheimer's disease.
Citation Information
Patent Citations
Anti-aging exosome-superoxide dismutase nano preparation and preparation method thereof
CN110251663A
Targeted modified astaxanthin-loaded cow milk exosome nano preparation and preparation method thereof
CN114982958A
Compound containing spirulina as well as preparation method and application of compound
CN115737828A
Schisantherin A for the treatment of neurodegenerative diseases
US20150366839A1
Cited By
RU.521-EVs anti-radiation nanogel as well as preparation method and application thereof
CN119970620A
